BioMarin Pharmaceutical Inc. using SYMBOL/TICKER code NASDAQ:BMRN has had its stock rating noted as ‘Initiated’ with the recommendation being set at ‘OVERWEIGHT’ yesterday by analysts at Morgan Stanley. BioMarin Pharmaceutical Inc. are listed in the Health Care sector within NASDAQ. Morgan Stanley have set their target price at 110 USD on its stock. This indicates the analyst believes there is a potential upside of 22.2% from the opening price of 90 USD.

BioMarin Pharmaceutical Inc. NASDAQ:BMRN has a 50 day moving average of 86.71 USD and a 200 Day Moving Average share price is recorded at 89.91 USD. The 1 year high stock price is 102.49 USD while the year low stock price is currently 62.12 USD. Over the last 30 and 90 trading days the company share price has increased 6.94 points and decreased 3.08 points respectively. There are currently 171,851,931 shares in issue with the average daily volume traded being 1,084,160. Market capitalisation for NASDAQ:BMRN is $15,279,355,815.00 USD.

Currency Pairs

Share Price Alerts

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.